Showing results (151-160 of 167) with videos related to

Sort By:
Pageof 17
The ISME Journal|September 9, 2017
Evidence for a primate origin of zoonotic Helicobacter suis colonizing domesticated pigsBram Flahou, Mirko Rossi, Jaco Bakker, et al.
Journal of Clinical Microbiology|March 11, 2016
Multicenter Evaluation of Clinical Diagnostic Methods for Detection and Isolation of Campylobacter spp. from StoolCollette Fitzgerald, Mary Patrick, Anthony Gonzalez, et al.
Infection Control and Hospital Epidemiology|July 21, 2021
Real-world impact of vaccination on coronavirus disease 2019 (COVID-19) incidence in healthcare personnel at an academic medical centerSarah E Waldman, Jason Y Adams, Timothy E Albertson, et al.
Plos One|June 24, 2021
SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC DavisDavid A Coil, Timothy Albertson, Shefali Banerjee, et al.
The Journal of Infectious Diseases|August 2, 2025
Comparability of gastrointestinal microbiome and bile acid profiles in patients with first or multiply recurrent Clostridioides difficile infectionJessica A Bryant, Timothy J Straub, Darrell S Pardi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2023
Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota-Based TherapeuticCharles S Berenson, Bret Lashner, Louis Y Korman, et al.
JAMA Network Open|February 13, 2023
Safety and Tolerability of SER-109 as an Investigational Microbiome Therapeutic in Adults With Recurrent Clostridioides difficile Infection: A Phase 3, Open-Label, Single-Arm TrialMatthew D Sims, Sahil Khanna, Paul Feuerstadt, et al.
Infectious Diseases and Therapy|June 28, 2024
Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDIColleen S Kraft, Matthew Sims, Michael Silverman, et al.
The New England Journal of Medicine|January 19, 2022
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile InfectionPaul Feuerstadt, Thomas J Louie, Bret Lashner, et al.
Open Forum Infectious Diseases|May 19, 2023
Baricitinib Treatment of Coronavirus Disease 2019 Is Associated With a Reduction in Secondary InfectionsDaniel A Sweeney, Bonifride Tuyishimire, Neera Ahuja, et al.
Pageof 17